다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
European journal of pharmacology, v.612 no.1/3, 2009년, pp.143 - 152
Wang, Changhe (School of Medicine, Xi'an Jiaotong University, Xi'an 710061, PR China) , Duan, Haijie (School of Medicine, Xi'an Jiaotong University, Xi'an 710061, PR China) , He, Langchong (Corresponding author. Tel.: +86 29 82656788)
AI-Helper
AbstractAngiogenesis is involved in the pathology of chronic inflammatory diseases. Application of anti-angiogenic strategies is beneficial in the treatment of inflammatory disorders. Atractylenolide I is an anti-inflammation agent. To further investigate the anti-angiogenesis mechanism of atractyle...
Lancet Balkwill 357 539 2001 10.1016/S0140-6736(00)04046-0 Inflammation and cancer: back to Virchow?
J. Neuropathol. Exp. Neurol. Beck 61 339 2002 10.1093/jnen/61.4.339 Cell type-specific expression of neuropilins in an MCA-occlusion model in mice suggests a potential role in post-ischemic brain remodeling
Mol. Biol. Cell Berse 3 211 1992 10.1091/mbc.3.2.211 Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors
Cancer Chemother. Pharmacol. Bocci 43 205 1999 10.1007/s002800050885 Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo
Cytokine Bryan 31 429 2005 10.1016/j.cyto.2005.06.015 Cytokine gene expression in a murine wound healing model
J. Pathol. Buttery 171 311 1993 10.1002/path.1711710412 Induction of nitric oxide synthase in the neo-vasculature of experimental tumours in mice
J. Biol. Chem. Clauss 271 17629 1996 10.1074/jbc.271.30.17629 The vascular endothelial growth factor receptor Flt-1mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis
FASEB Devy 16 147 2002 10.1096/fj.01-0552com The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent
Nucl. Med. Distler 47 149 2003 Angiogenic and angiostatic factors in the molecular control of angiogenesis
Biochim. Biophys. Acta Farndale 883 173 1986 10.1016/0304-4165(86)90306-5 Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue
J. Mol. Med. Ferrara 77 527 1999 10.1007/s001099900019 Molecular and biological properties of vascular endothelial growth factor
Cell Fischer 131 463 2007 10.1016/j.cell.2007.08.038 Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels
J. Natl. Cancer Inst. Gimbrone 52 413 1974 10.1093/jnci/52.2.413 Tumor growth and neovascularization: an experimental model using the rabbit cornea
Anal. Biochem. Green 126 131 1982 10.1016/0003-2697(82)90118-X Analysis of nitrate, nitrite and (15N) nitrate in biological fluids
Pharmacol. Rev. Griffioen 52 237 2000 Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases and chronic inflammation
Pharmacol. Rev. Hoeben 56 549 2004 10.1124/pr.56.4.3 Vascular endothelial growth factors and angiogenesis
Acta Bot. Sin. Huang 34 614 1992 Isolation and identification of atractylenolide VI from Atractylodes macrocephala Koidz
J. Ethnopharmacol. Huang 97 21 2005 10.1016/j.jep.2004.09.058 Reactive oxygen species mediation of Baizhu-induced apoptosis in human leukemia cells
FASEB J. Jackson 11 457 1997 10.1096/fasebj.11.6.9194526 The codependence of angiogenesis and chronic inflammation
Biochim. Biophys. Acta Jackson 1392 145 1998 10.1016/S0005-2760(98)00012-5 The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis
Med. Sci. Monit. Josko 10 89 2004 Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis
Human Pathol. Kaori 33 1069 2002 10.1053/hupa.2002.129420 Expression of vascular endothelial growth Factor, placental growth factor, and their Receptors flt-1 and KDR in human placenta under pathologic conditions
Semin. Cancer Biol. Klagsbrun 3 81 1992 Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions
Br. J. Cancer Knighton 35 347 1977 10.1038/bjc.1977.49 Avascular and vascular phases of tumor growth in the chick embryo
Science Koch 258 1798 1992 10.1126/science.1281554 Interleukin-8 as a macrophagederived mediator of angiogenesis
Mol. Cell. Biol. Laughner 21 3995 2001 10.1128/MCB.21.12.3995-4004.2001 HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression
Curr. Med. Chem. Leahy 7 1163 2000 10.2174/0929867003374336 Role of cyclooxygenases in angiogenesis
Sci. China, Ser. C Life Sci. Li 49 182 2006 10.1007/s11427-006-0182-7 Establishment of the model of white blood cell membrane chromatography and screening of antagonizing TLR4 receptor component from Atractylodes macrocephala Koidz
J. Ethnopharmacol. Li 114 212 2007 10.1016/j.jep.2007.08.002 Screening for the anti-inflammatory activity of fractions and compounds from Atractylodes macrocephala koidz
First Milit. Med. Univ. Liu 25 1308 2005 Effects of lactone I from Atractylodes macrocephala Koidz on cytokines and proteolysis-inducing factors in cachectic cancer patients
Nat. Med. Luttun 8 831 2002 10.1038/nm731 Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1
Proc. Natl. Acad. Sci. U. S. A. Maglione 88 9267 1991 10.1073/pnas.88.20.9267 Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor
J. Allergy Clin. Immunol. Margaret 120 3 2007 10.1016/j.jaci.2007.05.017 Modulating leukocyte recruitment in inflammation
J. Hepatol. Medina 42 124 2005 10.1016/j.jhep.2004.09.024 Evidence of angiogenesis in primary biliary cirrhosis: an immunohistochemical descriptive study
Cancer Res. Ng 63 3189 2003 Antiangiogenic activity of N-substituted and tetrafluorinated thalidomide analogues
Lab. Invest. Nicosia 63 115 1990 Growth of microvessels in serum-free matrix culture of rat aorta: a quantitative assay of angiogenesis in vitro
J. Biol. Chem. Park 269 25646 1994 10.1016/S0021-9258(18)47298-5 Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR
Biochem. Biophys. Res. Commun. Pepper 181 902 1991 10.1016/0006-291X(91)91276-I Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells
Curr. Top. Microbiol. Immunol. Persico 237 31 1999 Structure expression and receptor-binding properties of placental growth factor (PlGF)
FEMS Microbiol. Immunol. Pugh-Humphreys 5 289 1992 10.1111/j.1574-6968.1992.tb05914.x Macrophage-neoplastic cell interactions: implications for neoplastic cell growth
Nature Risau 386 671 1997 10.1038/386671a0 Mechanisms of angiogenesis
Cancer Lett. Shin 159 127 2000 10.1016/S0304-3835(00)00522-X Effects of tumor necrosis factor-alpha and interferon-gamma on expression of matrix metalloproteinase-2 and -9, in human bladder cancer cells
J. Leukoc. Biol. Sunderkotter 55 410 1994 10.1002/jlb.55.3.410 Macrophages and angiogenesis
Arthritis Res. Walsh 31 147 2001 10.1186/ar292 Angiogenesis in the pathogenesis of inflammatory joint and lung diseases
Food Chem. Toxicol. Wang 44 1308 2006 10.1016/j.fct.2006.02.008 Pro-oxidant and cytotoxic activities of atractylenolide I in human promyeloleukemic HL-60 cells
Cancer Ther. Waterston 2 131 2004 TNF and cancer: good or bad
J. Mol. Cell. Cardiol. Zhang 31 1005 1999 10.1006/jmcc.1999.0944 Appearance and regression of rat pouch tissue
Chin. Med. Mater. Zhang 22 636 1999 Gastrointestinal inhibitory effects of sesquiterpene lactones from Alractylodes macrocephala
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.